How's the Capital Raise Going to Work?, page-99

Lets see what tge June conference brings. IMU had the same with B cell data some years ago. they weren't allowed to release until it was announced at the conference.

That is a pure guess. But all previous cohorts would havd had a read out to the market by now.

I dont think you would rock up to a conference if your drug wasnt doing something special. Nor would the hospital that is running the trial give approval for an expansion trial if it didnt see something it liked.